Variation in Routine Use of a 60 to 63 Gy Intermediate Dose Clinical Target Volume With Primary Radiation therapy for Mucosal Squamous Cell Carcinoma of the Head and Neck

Laura Freedman, Thomas Galloway, Kenneth Hu, Michelle Mierzwa

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Variation in Routine Use of a 60 to 63 Gy Intermediate Dose Clinical Target Volume With Primary Radiation therapy for Mucosal Squamous Cell Carcinoma of the Head and Neck'. Together they form a unique fingerprint.

Medicine and Dentistry